MetLife Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $449K | Sell |
|
|||||
|
2024
Q4 | $296K | Buy |
|
|||||
|
2024
Q3 | $169K | Sell |
|
|||||
|
2024
Q2 | $186K | Buy |
|
|||||
|
2024
Q1 | $128K | Sell |
|
|||||
|
2023
Q4 | $167K | Hold |
|
|||||
|
2023
Q3 | $133K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $116K | Buy |
|
|||||
|
2022
Q4 | $34.4K | Sell |
|
|||||
|
2022
Q3 | $111K | Hold |
|
|||||
|
2022
Q2 | $109K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $134K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $138K | Hold |
|
|||||
|
2019
Q2 | $161K | Buy |
|